(+)-prostaglandin A2,
(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic acid,
(Z)-7-((1R,2S)-2-((E)-(3S)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic acid,
Medullin,
PGA2,
prostaglandin A2,
prostaglandin A2,
PGA2,
Medullin,
13345-50-1,
5,6-cis-PGA2,
(15S)-Prostaglandin A2,
(15S)-PGA2,
(+)-Prostaglandin A(sup 2),
PGA(sup 2),
UNII-K6VT5BDY9E,
5,6-cis-PGA(sup 2),
Prostaglandin A(sup 2),
K6VT5BDY9E,
15(S)-Prostaglandin A2,
(155)-PGA2,
NSC 165561,
BRN 2221844,
(+)-Prostaglandin A2,
CHEBI:27820,
MYHXHCUNDDAEOZ-FOSBLDSVSA-N,
9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid,
Prosta-5,10,13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-,
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic acid,
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic acid,
(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid,
Prostaglandin A2 solution,
5-Heptenoic acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)-,
MLS000069589,
SMR000058790,
AC1NQXPP,
BSPBio_001460,
BML1-F02,
GTPL6279,
SCHEMBL2115595,
CHEMBL1084643,
Prosta-5,10,13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-,
HMS1361I22,
HMS1791I22,
HMS1989I22,
HMS3402I22,
HMS3648I11,
(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid,
ZINC4521813,
1999AH,
LMFA03010035,
IDI1_033930,
NCGC00022061-03,
NCGC00022061-04,
NCGC00022061-05,
LS-125845,
C05953,
SR-01000946222,
SR-01000946222-1,
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoate,
BRD-K34782918-001-02-5,
15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate,
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate,
15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid,
15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate,
362927F3-3A3E-47BC-84C3-C32A293AA956,
15.alpha.-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid,
15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid,
15.alpha.-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid,
Prosta-5,10-13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-,
5-Heptenoic acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (VAN),
5-Heptenoic acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (VAN) (8CI),
Prosta-5,10-13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)- (9CI),
(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]hept-5-enoic acid,
(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]hept-5-enoic acid,
D07LNY,
PGA2 (Prostaglandin A2),
FA(20:3(OH,Ke,cyclo)),
C20H30O4,
C20-H30-O4,
CID5280880,
C100008,
(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic acid,
(Z)-7-((1R,2S)-2-((E)-(3S)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic acid,